Navigation Links
Organogenesis, Inc. to Develop Regenerative Medicine Therapies for U.S. Military Battlefield Injuries
Date:4/17/2008

enefit people in the civilian population with burns or severe trauma.

In addition to its clinical research activities, the AFIRM will create cooperative partnerships with industry to ensure that the technical innovations emerging from the research will transition rapidly into militarily relevant therapies and result in producible technologies, and ultimately will be translated into civilian population applications as well. The AFIRM will incorporate a close integration between basic science research and translational and clinical research in order to bring to practice effective regenerative medicine therapies.

The Wake Forest-University of Pittsburgh team has committed to develop clinical therapies over the next five years that will focus on the following five areas:
-- Burn repair

-- Wound healing without scarring

-- Craniofacial reconstruction

-- Limb reconstruction, regeneration or transplantation

-- Compartment syndrome, a condition related to inflammation after surgery

or injury that can lead to increased pressure, impaired blood flow,

nerve damage and muscle death

Collaborators for the Wake Forest-McGowan team include Organogenesis, Inc., Tufts University, Allegheny Singer Research Institute, the California Institute of Technology, Carnegie Mellon University, Georgia Institute of Technology, Intercytex, North Carolina State University, Oregon Medical Laser Center at Providence St. Vincent Medical Center, Pittsburgh Tissue Engineering Initiative, Rice University, the Stanford University School of Medicine, the University of California, Santa Barbara, the University of North Carolina, the University of Texas Health Science Center at Houston, the University of Wisconsin, and Vanderbilt University.

More than 50 technologies from the AFIRM team already have had a wide impact on treatments for illness and injury. Researchers have launched more than 10 clinical trials (three with the Arm
'/>"/>

SOURCE Organogenesis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
4. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
5. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
6. Global Experts Explore Entire Spectrum of Aids Vaccine Development
7. Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents
8. Vical Names Andrew de Guttadauro Vice President, Corporate Development
9. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
10. SemBioSys updates Apo AI development program
11. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... the acquisition of Durata Therapeutics, Inc. by Actavis, PDL ... termination of PDL,s credit agreement with Durata, which included ... million, accrued interest, and prepayment and change of control ... financing transaction with Durata in which PDL agreed to ...
(Date:11/17/2014)... The new METTLER TOLEDO White Paper ... challenges of becoming the first calibration laboratory in ... weights in the microgram range. National Metrology Institutes ... scientists involved in nanotechnology applications will benefit from ... calibration of weights in the range of 0.05 ...
(Date:11/15/2014)... (PRWEB) November 13, 2014 Collaborative Consulting, ... they were named one of the Boston Globe’s “Top ... Medium Sized Businesses in Massachusetts to receive the honor. ... employers who take care of their most valuable resource: ... are presented annually, and are based on an array ...
(Date:11/15/2014)... November 14, 2014 CannLabs, ... proprietary, cloud-based analytics, and scientific testing methodologies relating ... third quarter ended September 30, 2014, and provided ... ,     CannLabs – Nevada, Inc. granted ... Nevada. ,     CannLabs – Connecticut, Inc. opened ...
Breaking Biology Technology:PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics 2New White Paper on Microgram Weights Describes How to Achieve Traceable Measurement Down to 0.05 Milligrams 2Collaborative Consulting Honored with Boston Globe Top Places to Work 2014 2CannLabs Announces Third Quarter 2014 Results. 2CannLabs Announces Third Quarter 2014 Results. 3CannLabs Announces Third Quarter 2014 Results. 4CannLabs Announces Third Quarter 2014 Results. 5
... The Committee for,Medicinal Products for Human Use ... a negative opinion on a Cymbalta(R) (duloxetine,hydrochloride) application ... and Company and Boehringer Ingelheim are naturally,disappointed by ... director for duloxetine, Eli Lilly and Company. "We ...
... announced the availability of a 100% organic toxic mold remedy for ... based on the same technology used effectively in the aftermath of ... ... CA (PRWEB) October 24, 2008 -- Organic Environmental Technology ( http://www.organicet.com ...
... DIEGO, Oct. 23 Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ... in,San Diego on Tuesday, October 28, 2008 at 10:30 ... Finance and Chief Financial Officer, will,be providing a corporate ... and a recording will be made,available following the event. ...
Cached Biology Technology:European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 2European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 3European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 4European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 5Katrina Proven Certified Organic Toxic Mold Remedy Now Available for Mold Remediation Professionals and Homeowners 2Katrina Proven Certified Organic Toxic Mold Remedy Now Available for Mold Remediation Professionals and Homeowners 3Katrina Proven Certified Organic Toxic Mold Remedy Now Available for Mold Remediation Professionals and Homeowners 4
(Date:11/4/2014)... 2014   Neurotechnology , a provider of ... latest version of its fingerprint matching algorithm has ... evaluation organized by NIST. The MINEX test ... INCITS 378 fingerprint standard template format. MINEX compliance ... in the United States ...
(Date:11/3/2014)... 3, 2014  NeuroSigma ® , Inc. (NeuroSigma), ... company focused on commercialization of its non-invasive ... treatment of neurological and neuropsychiatric disorders, announced today ... issued a Notice of Allowance for Mexican Patent ... by NeuroSigma and the Regents of the University ...
(Date:11/2/2014)... LA (2 November 2014)—In support of a bold quest ... & Melinda Gates Foundation today announced an award of ... Vaccine Initiative (MVI) in building new vaccines that will ... realize the "accelerating to zero" agenda. Such vaccines would ... could be called an "immunological bed net." , ...
Breaking Biology News(10 mins):Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 4
... if $5.1 billion in new resources for preventive and ... from the Johns Hopkins Bloomberg School of Public Health ... deaths occur in 42 countries around the world. In ... be $887 or $1.23 per capita. With the recent ...
... northern and southern hemispheres are linked by a phenomenon by ... the planet. A research team from the Universitat Autònoma de ... time that ocean circulation in the southern hemisphere has, in ... research published today in Science will enable more accurate forecasts ...
... a NASA mission, which they believe could reveal living matter ... , NASA's Deep Impact spacecraft will make a historic encounter ... will crash into the comet and tunnel through its outer ... dust. , UK astronomers involved in monitoring the comet before, ...
Cached Biology News:$5.1 billion would save 6 million children 2$5.1 billion would save 6 million children 3Climatologists discover deep-sea secret 2NASA probe could reveal comet life, scientists claim 2
... polyacrylamide gel electrophoresis (2D-PAGE) with biological mass ... technology platform for proteomic analysis. 2D-PAGE gels ... limited only in the dynamic range and ... Quantitative image based analysis of separated proteins ...
... The BV-10 offers precision ... 0.1 and 50m. The unique ... vibration free for greater control ... can be accomplished very rapidly ...
... EC570-90 is a compact, lightweight, high current power ... or 2500 milliamps. It is an excellent choice ... gels. It is also ideal for all types ... be set to automatically end a run and ...
... is a highly purified preparation qualified to ... vectors. The preparation is functionally tested for ... of detectable contaminating proteases. Prepared from human ... tests to be negative for HBsAg and ...
Biology Products: